The investigators study is the randomized controlled study for analyzing clinical benefit of pain focused sedation with combination of fentanyl and propofol during Endoscopic retrograde cholangiopancreatography (ERCP). The investigators will assess recovery time and adverse effect during ERCP as the primary end point between two group. The investigators will also access satisfaction score for endoscopist and patients as the secondary end point.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
SINGLE
Enrollment
220
Propofol Meperidine : 25 mg IV just before procedure * IV bolus of 1 mg/kg for sedation induction, * Infusion of 60 mcg/min/kg for maintenance of sedation * Additional bolus dose of 10mg as needed for adequate sedation
Fentanyl * IV bolus of 1 µg/kg for sedation induction * Additional bolus dose of 0.5 µg/kg as needed for adequate pain control Propofol * IV bolus of 0.4 mg/kg for sedation induction * Infusion of 30 µg/min/kg for maintenance of sedation * Additional bolus dose of 10mg as needed for adequate depth of sedation
Severance Hospital, Yonsei University
Seoul, Seoul, South Korea
Recovery time
Recovery time (time from scope withdrawal to full recovery)
Time frame: time from scope withdrawal to full recovery at averange 24 hours
Adverse event during and after procedure
Adverse event during and after procedure i. Desaturation rate ii. Apnea
Time frame: measurements of recovery time during ERCP procedure & after ERCP procedure at average 24 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.